Health ❯Healthcare ❯Public Health ❯Disease Prevention

HIV Prevention

WHO Recommends Six-Monthly Lenacapavir Injection for HIV Prevention

Trials demonstrating near-perfect efficacy have paved the way for a six-monthly PrEP injection under new voluntary licensing in 120 countries.

Lenacapavir Named 'Breakthrough of the Year' for Advancing HIV Prevention

New HIV Drug Could Revolutionize Prevention at Just $40 Annually